drugset / Trial / NCT00267319
FOCUS Fatigue Outcome in Copaxone USers
Non-randomizedSingle-groupOpen-labelTreatment
Summary
* The study primarily investigates the effect of copaxone on fatigue during treatment, compared to baseline in patients with relapsing-remitting multiple sclerosis. * Secondary outcome measures are:disability, relapse rate, quality of life and depression.
Timeline
- Start
- 2003-06
- Primary completion
- 2006-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glatiramer Acetate | Small molecule | — | — |